According to a research, about one in eight women suffer from the breast cancer in their lifetime. Furthermore, the death rate of the breast cancer is higher than any other types of cancer. The breast cancer is regarded as a conundrum. However, a team of researchers from the University of Zurich in Switzerland has found a way to invent a treatment for the breast cancer. They developed the new way to destroy cancer cell that they were not able to kill before.
Currently, antibodies such as pertuzumab and trastuzumab are used for the treatment of breast cancer. They detect and target HER2 which plays a vital role in the breast cancer. However, the antibodies only deactivate cancer cells, so cancer cells can be reactivated at any time.
The researchers wanted to find the reason why the antibodies cannot totally destroy the breast cancer cells. They figured out that HER2 uses multiple signaling pathways to develop and reproduce cancer cells, but commonly used antibodies are formed to only block one signaling pathway, which enables cancer cells to recrudesce.
The researchers also found out a solution to overcome the lack of antibodies. They made a protein compound which is able to combine itself with two HER2 receptors and change the structure of receptors. It prevents the growth signals from the RAS, a central hub in the cell, and reactivates the signals released by the HER2 receptor. Furthermore, the antibodies might have negative effects, attacking the healthy body cells, but this protein compound only targets the cancer cells.
It is expected that the way treating breast cancer will be more opened in the future through this research